Angsuman Chakraborty08 May 2008 01:29 am
Bio-heart has finally revealed the data of its seismic trial. It shows that Myocell Myoblast clinical cell therapy is good way to improve heart problems like cardiac devices and congested heart diseases. Researchers also say that the treatment is a safe one. The research was conducted with 26 patients receiving Myocell therapy, against 14 patients in control group. All of them were patients of heart disease, receiving standard medical treatment. Six month of trial revealed that almost 84% of the patient were improved.
Patrick Serruys, of the research team, says that the MyoCell Myoblast clinical cell therapy, has shown interesting results. The main concern is safety, however the study shows positive trends in clinical benefit, he further added.
Source: Pharmaceutical Business Review
Filed under Heart, Stem Cell | 3 Comments
Related?
Own bone marrow stem cell effective for heart patientsOctober 31st, 2008 A Britain stem cell clinical trial has raised hope for those heart patients. The study finds that a heart patient could dramatically improve survival and quality of life, if the stem cell from his own heart can be delivered into his heart.
Stem Cell Trial for Heart Attack Approved by FDAMay 7th, 2007 Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company,
Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks. The Phase 2 clinical trial will be based at the Texas Heart Institute, and will follow a similar protocol to the one used by the same investigators in preclinical studies for the IND submission.
Heart Attack Patient "100%" After Experimental Stem Cell Treatment April 26th, 2008 Mr Robin Marston, a 61-year-old bus driver from West Drayton in London, has taken part in a new clinical trial, a pioneering stem-cell program at The Barts and The London Heart Attack Center. In the first clinical trial of its kind, Doctors took stem cells from bone marrow in lower back of the patient.
Stem Cell Product Trial to Treat Heart Attack Receives FDA Clearance May 10th, 2007 Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks. The Phase 2 clinical trial will be based at the Texas Heart Institute, and will follow a similar protocol to the one used by the same investigators in preclinical studies for the IND submission.
Stem Cell Clinical Trial for Heart Attack Patients Reaches Safety MilestoneNovember 6th, 2005 Osiris Therapeutics, Inc. announced today that its multi-center, human clinical stem cell trial for the treatment of patients suffering from heart attacks has successfully passed the first safety milestone of the trial.
Stem cells from bone marrow effectively help open blocked arteriesMay 23rd, 2009 Researchers from Netherlands have claimed that Injecting bone marrow stem cells into the heart's muscular wall could restore blood flow to hearts with blocked arteries. Dutch researcher Jan van Ramshorst of Leiden University Medical Center and colleagues have shown in a small trial that stem cell injection can helped blood flow, reduced pain and even helped patients to exercise adequately.
Machine Technology and Biotechnology join hands for stem cell clinical trialJune 15th, 2009 This human trial is designed to evaluate the safety and efficacy of Cardio3 BioSciences second generation stem cell therapy in patients with heart failure. The first patient was treated in March 2009.
Kidney damage can now be cured by stem cell therapyOctober 2nd, 2008 Report shows that any major surgery done on any parts of the body puts great stress on the body's organs, none more so than the kidneys, and half of patients who suffer kidney damage during surgery die, while others need a lifelong dialysis or kidney transplants. And keeping this in mind researchers at Intermountain Medical Center for the first time have launched a new safety study of an investigational adult stem cell treatment that may repair kidney damage suffered during heart surgery.
3 Responses
Leave a Comment
May 22nd, 2008 at 4:53 pm
I could benefit from this trial. My EF is 15-20. Please send me information on how to take part in a study.
August 1st, 2008 at 5:29 am
Hi Samuel,
Hopefully the following website will be helpful for you- https://www.bioheartinc.com [www.bioheartinc.com]
Get well soon.
March 10th, 2009 at 7:39 pm
I have hardening of my arteries, & have had 1 heart attack. My Dr. says I can not get an operation on my heart. I would love to take part in a stem cell trial for the heart that might help me. I have insurance, but very little money. Can you help me?